Current Vascular Pharmacology publishes clinical and research-based reviews/mini-reviews, original research articles, letters, debates, drug clinical trial studies and guest edited issues to update all those concerned with the treatment of vascular disease, bridging the gap between clinical practice and ongoing research.Vascular disease is the commonest cause of death in Westernized countries and its incidence is on the increase in developing countries. It follows that considerable research is directed at establishing effective treatment for acute vascular events. Long-term treatment has also received considerable attention (e.g. for symptomatic relief). Furthermore, effective prevention, whether primary or secondary, is backed by the findings of several landmark trials. Vascular disease is a complex field with primary care physicians and nurse practitioners as well as several specialties involved. The latter include cardiology, vascular and cardio thoracic surgery, general medicine, radiology, clinical pharmacology and neurology (stroke units).
《当代血管药理学》出版临床和研究综述/小型综述、原创研究文章、信件、辩论、药物临床试验研究和客座编辑期刊，以更新所有与血管疾病治疗有关的内容，弥合临床实践和正在进行的研究之间差距。血管疾病是西方国家最常见的死亡原因，其发病率在发展中国家呈上升趋势。因此，大量研究旨在建立急性血管事件的有效治疗方法。长期治疗也受到了相当大的关注（例如症状缓解）。此外，有效的预防，无论是初级还是次级，都得到了几项里程碑式试验结果的支持。血管疾病是一个复杂的领域，涉及初级保健医生和护士以及几个专业。后者包括心脏病学、血管和心胸外科、普通医学、放射学、临床药理学和神经病学（卒中单元）。
Anti-Angiogenic Activity of Curcumin in Cancer Therapy: A Narrative Review.
来源期刊：Current vascular pharmacologyDOI：10.2174/1570161116666180209113014
Switching Dipeptidyl Peptidase-4 Inhibitors to Tofogliflozin, a Selective Inhibitor of Sodium-Glucose Cotransporter 2 Improve Arterial Stiffness Evaluated by Cardio-Ankle Vascular Index in Patients with Type 2 Diabetes: A Pilot Study.
来源期刊：Current vascular pharmacologyDOI：10.2174/1570161116666180515154555
Pleiotropic Effects of Statins: Untapped Potential for Statin Pharmacotherapy.
来源期刊：Current vascular pharmacologyDOI：10.2174/1570161116666180723120608
Postprandial Hypertriglyceridaemia Revisited in the Era of Non-Fasting Lipid Profile Testing: A 2019 Expert Panel Statement, Main Text
来源期刊：Current vascular pharmacologyDOI：10.2174/1570161117666190507110519
Patient Adherence to Novel Oral Anticoagulants (NOACs) for the Treatment of Atrial Fibrillation and Occurrence of Associated Bleeding Events: A Systematic Review and Meta-analysis.
来源期刊：Current vascular pharmacologyDOI：10.2174/1570161116666180123111949
Cardiovascular Risk in Psoriasis: Current State of the Art.
来源期刊：Current vascular pharmacologyDOI：10.2174/1570161115666171116163816
Uncaria rhynchophylla and Its Major Constituents on Central Nervous System: A Review on Their Pharmacological Actions.
来源期刊：Current vascular pharmacologyDOI：10.2174/1570161117666190704092841
Microvascular complications of type 2 diabetes mellitus.
来源期刊：Current vascular pharmacologyDOI：10.2174/1570161117666190502103733
Herbal Medicine for Slowing Aging and Aging-Associated Conditions: Efficacy, Mechanisms, and Safety.
来源期刊：Current vascular pharmacologyDOI：10.2174/1570161117666190715121939
Prevention of Vascular Complications in Diabetes Mellitus Patients: Focus on the Arterial Wall.
来源期刊：Current vascular pharmacologyDOI：10.2174/1570161116666180206113755
Gender-specific, Lifestyle-related Factors and 10-year Cardiovascular Disease Risk; the ATTICA and GREECS Cohort Studies.
来源期刊：Current vascular pharmacologyDOI：10.2174/1570161116666180608121720
Postprandial Hypertriglyceridaemia Revisited in the Era of Non-Fasting Lipid Profile Testing: A 2019 Expert Panel Statement, Narrative Review
来源期刊：Current vascular pharmacologyDOI：10.2174/1570161117666190503123911
Cardiovascular Disease in Spondyloarthritides
来源期刊：Current vascular pharmacologyDOI：10.2174/1570161117666190426164306
Genetic Variations and Subclinical Markers of Carotid Atherosclerosis in Patients with Type 2 Diabetes Mellitus.
来源期刊：Current vascular pharmacologyDOI：10.2174/1570161116666180206112635
Maternal Dyslipidaemia in Pregnancy with Gestational Diabetes Mellitus: Possible Impact on Foetoplacental Vascular Function and Lipoproteins in the Neonatal Circulation.
来源期刊：Current vascular pharmacologyDOI：10.2174/1570161115666171116154247
Aortic Stenosis, Aortic Regurgitation and Arterial Hypertension.
来源期刊：Current vascular pharmacologyDOI：10.2174/1570161116666180101165306
Diabetes and heart failure: Is it hyperglycemia or hyperinsulinemia?
来源期刊：Current vascular pharmacologyDOI：10.2174/1570161117666190408164326
Pharmacological Management of Cardiac Disease in Patients with Type 2 Diabetes: Insights into Clinical Practice
来源期刊：Current vascular pharmacologyDOI：10.2174/1570161117666190426162746
Associations between Adiponectin Gene Variability, Proinflammatory and Angiogenetic Markers: Implications for Microvascular Disease Development in Type 2 Diabetes Mellitus?
来源期刊：Current vascular pharmacologyDOI：10.2174/1570161116666180108113825
Cardiovascular Risk in Rheumatoid Arthritis and Mechanistic Links: From Pathophysiology to Treatment.
来源期刊：Current vascular pharmacologyDOI：10.2174/1570161117666190619143842
Clinical Presentation, Quality of Care, Risk Factors and Outcomes in Women with Acute ST-Elevation Myocardial Infarction (STEMI): An Observational Report from Six Middle Eastern Countries.
来源期刊：Current vascular pharmacologyDOI：10.2174/1570161116666180315104820
Does Perioperative Hemoglobin A1c Level Affect the Incidence, Pattern and Mortality of Lower Extremity Amputation?
来源期刊：Current vascular pharmacologyDOI：10.2174/1570161116666180123112529
Novel Hypolipidaemic Drugs: Mechanisms of Action and Main Metabolic Effects.
来源期刊：Current vascular pharmacologyDOI：10.2174/1570161116666180209112351
Screening for Rare Genetic Variants Associated with Atherosclerosis: Opportunity for Personalized Medicine.
来源期刊：Current vascular pharmacologyDOI：10.2174/1570161116666180206111725
Non-Traditional Cardiovascular Risk Markers in the Era of Established Major Risk Factors and Multiple Guidelines.
来源期刊：Current vascular pharmacologyDOI：10.2174/1570161116666180123112956
Treatment of Diabetic Cardiovascular Autonomic, peripheral and painful neuropathy. Focus on the treatment of Cardiovascular Autonomic Neuropathy with ACE inhibitors.
来源期刊：Current vascular pharmacologyDOI：10.2174/1570161117666190521101342
Metabolic complications and kidney transplantation: focus on glycaemia and dyslipidaemia.
来源期刊：Current vascular pharmacologyDOI：10.2174/1570161117666190619143005
Advanced Glycation End Products in Chinese Medicine Mediated Aging Diseases: A Review.
来源期刊：Current vascular pharmacologyDOI：10.2174/1570161117666190507112157
Renal Dysfunction Following Elective Endovascular Aortic Aneurysm Repair.
来源期刊：Current vascular pharmacologyDOI：10.2174/1570161115666171116163203
Galectin-3 and Arterial Stiffness in Patients with Heart Failure: A Pilot Study.
来源期刊：Current vascular pharmacologyDOI：10.2174/1570161116666180703094919
Efficacy of P2Y12 Receptor Blockers After Myocardial Infarction and Genetic Variability of their Metabolic Pathways.
来源期刊：Current vascular pharmacologyDOI：10.2174/1570161116666180206110657
The Role of Percutaneous Coronary Intervention in the Treatment of Chronic Total Occlusions: Rationale and Review of the Literature.
来源期刊：Current vascular pharmacologyDOI：10.2174/1570161116666180117100635
Antithrombotic Therapy in Lower Extremity Artery Disease.
来源期刊：Current vascular pharmacologyDOI：10.2174/1570161117666190206230516
Menopause and its Cardiometabolic Consequences: Current Perspectives.
来源期刊：Current vascular pharmacologyDOI：10.2174/1570161117999190228123237
Hypertriglyceridemia: An Infrequent, Difficult-to-Predict, Severe Metabolic and Vascular Problem Associated with Estrogen Administration.
来源期刊：Current vascular pharmacologyDOI：10.2174/1570161117666190306102322
Use of Alternative Antiplatelet Agents for Clopidogrel Hypersensitivity.
来源期刊：Current vascular pharmacologyDOI：10.2174/1570161116666180730100806
Arterial Stiffness, Cognitive Dysfunction, and Adherence to Antihypertensive Agents. Is there a Link to Hypertensive Patients?
来源期刊：Current vascular pharmacologyDOI：10.2174/1570161117666190415112953
Effects of Intensive Blood Pressure Control in Patients with Evident Cardiovascular Disease: An Investigation Using the SPRINT Study Data.
来源期刊：Current vascular pharmacologyDOI：10.2174/1570161116666180305160116
Treatment of Clopidogrel Hypersensitivity: The Jefferson Approach.
来源期刊：Current vascular pharmacologyDOI：10.2174/1570161116666180730100346
The Significance of Pain in Chronic Venous Disease and its Medical Treatment.
来源期刊：Current vascular pharmacologyDOI：10.2174/1570161116666180209111826
The endothelial glycocalyx as a key mediator of albumin handling and the development of diabetic nephropathy.
来源期刊：Current vascular pharmacologyDOI：10.2174/1570161118666191224120242
Is Atherothromboaspiration a Possible Solution for the Prevention of No-Reflow Phenomenon in Acute Coronary Syndromes? Single Centre Experience and Review of the Literature.
来源期刊：Current vascular pharmacologyDOI：10.2174/1570161116666180101150956
Statins and Elderly: From Clinical Trials to Daily Practice.
来源期刊：Current vascular pharmacologyDOI：10.2174/1570161116666180628145723
Complementary and Alternative Medicine for the Treatment of Insomnia: An Overview of Scientific Evidence from 2008 to 2018.
来源期刊：Current vascular pharmacologyDOI：10.2174/1570161117666190506111239
Statins: Pharmacokinetics, Pharmacodynamics and Cost-Effectiveness Analysis.
来源期刊：Current vascular pharmacologyDOI：10.2174/1570161116666180706144824
Clopidogrel Desensitization: Background and Recommendations for Use of a Rapid (4 Hour) Protocol.
来源期刊：Current vascular pharmacologyDOI：10.2174/1570161116666181031101930
Mandatory Reporting of Coronary Artery Calcifications Incidentally Noted on Chest Multi-Detector Computed Tomography: A Multicentre Experience.
来源期刊：Current vascular pharmacologyDOI：10.2174/1570161116666180117111856
Cardiovascular Disease in Antiphospholipid Syndrome.
来源期刊：Current vascular pharmacologyDOI：10.2174/1570161117666190830101341
Is there Sex-related Outcome Difference According to oral P2Y12 Inhibitors in Patients with Acute Coronary Syndromes? A Systematic Review and Meta-Analysis of 107,126 Patients.
来源期刊：Current vascular pharmacologyDOI：10.2174/1570161116666180123092054
What Does the Future Hold for Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis?
来源期刊：Current vascular pharmacologyDOI：10.2174/157016111705190703102816
